EC Number   |
Posttranslational Modification |
Reference |
|---|
   2.7.10.1 | glycoprotein |
- |
490141, 490179, 490215, 490331, 490352, 490501, 490502, 490506, 490539, 490543, 490546 |
| 2.7.10.1 | glycoprotein |
EGFR |
661551 |
| 2.7.10.1 | glycoprotein |
epidermal growth factor receptor contains a glycosylated extracellular domain |
660727 |
| 2.7.10.1 | glycoprotein |
ErbB family proteins are N-glycosylated to about 20% of their mass, deglycosylation causes loss of 70% protein tyrosine kinase activity |
660873 |
| 2.7.10.1 | glycoprotein |
extracellular domain of FLT4 consists of 7 immunoglobulin-like loops, including 12 potential glycosylation sites |
490396 |
| 2.7.10.1 | glycoprotein |
five potential N-linked glycosylation sites |
490522 |
| 2.7.10.1 | glycoprotein |
FLT-3 and FLT-3 ITD are high-mannose-type glycoproteins |
662856 |
| 2.7.10.1 | glycoprotein |
glycosylation sites on the extracellular domain |
490603 |
| 2.7.10.1 | lipoprotein |
Gly2, Cys3, Lys7, and Lys9 are required for efficient binding of p59fyn to the TCR and for efficient fatty acylation, myristoylation at Gly2 and palmitoylation at Cys3 |
490417 |
| 2.7.10.1 | lipoprotein |
palmitoylation of p59fyn is reversible and sufficient for plasma membrane association |
490418 |
